Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1298 clinical trials
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma

This study aims to test the safety of hepatic artery infusion pump placement, a standard surgical procedure, and intraarterial chemotherapy initiation with the standard medication floxuridine (FUDR), using the Medtronic Synchromed II pump combined with the Codman arterial catheter in patients with unresectable (not removable by surgery) liver metastases from …

dexamethasone
metastatic adenocarcinoma
systemic chemotherapy
neutrophil count
colorectal adenocarcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma

The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).

hepatocellular carcinoma metastatic
metastatic hepatocellular carcinoma
lenvatinib
liver cancer
unresectable hepatocellular carcinoma
  • 0 views
  • 05 Aug, 2020
Bintrafusp Alfa in Previously Treated Patients With Recurrent and Metastatic (R/M) Non-keratinizing Nasopharyngeal Carcinoma (NPC)

This would be a phase II prospective single arm mono-institutional study conducted in Queen Mary Hospital (Hong Kong) assessing the efficacy and safety of bintrafusp alfa in previously treated patients with recurrent and metastatic (R/M) non-keratinizing nasopharyngeal carcinoma (NPC).

neutrophil count
serum total bilirubin level
adjuvant
nasopharyngeal carcinoma
measurable disease
  • 0 views
  • 16 Feb, 2024
  • 1 location
The Renal Deterioration Between Adjusted Dose TDF and Switching to TAF in CHB With Renal Impairment

TAF has a higher plasma stability than TDF, which makes TDF require a higher dose to get the concentration of drugs in the liver equal to the amount of TAF. Previous studies have shown the effects of TAF once daily and TDF once daily on kidney function and bone mass.

hepatitis b
renal impairment
renal function
HIV Infection
renal function test
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

This is an open-label, randomized study comparing a monitored ketogenic diet intervention using standard ketogenic diet (SKD) and standard of care (SOC) dietary recommendations for 16 weeks. Subjects enrolled in the standard of care group will receive a voucher to Weight Watchers after study completion.

cirrhosis
fatty liver
ketogenic diet
  • 0 views
  • 16 Feb, 2024
  • 1 location
Heeba Test Trial  

This study is looking for individuals 18 to 65 years old with PKU. Sanofi believes that everyoneshould have the opportunity to take part in clinical trials. It is important to include people whohave been historically under-represented in clinical trials. Sanofi is committed to inclusivity inour studies.If you are interested in …

  • 0 views
  • 24 Feb, 2025
  • 3 locations
Sujana-A Phase 1/Phase 2 open-label study to evaluate the safety, tolerability, and efficacy of a single intravenous administration of an investigational medication in adult participants with phenylketonuria (PKU)  

This study is looking for individuals 18 to 65 years old with PKU. Sanofi believes that everyoneshould have the opportunity to take part in clinical trials. It is important to include people whohave been historically under-represented in clinical trials. Sanofi is committed to inclusivity inour studies.If you are interested in …

  • 0 views
  • 13 Nov, 2023
  • 1 location
A Study of Oral Tazemetostat in Subjects With Moderate and Severe Hepatic Impairment With Advanced Malignancies

This is a phase 1, 2-part, global, multicenter, open-label, PK, safety and tolerability study of oral tazemetostat in subjects with either advanced solid tumors, or hematological malignancies and normal hepatic function or moderate, or severe hepatic impairment.

solid tumour
renal function
HIV Infection
hemolysis
opportunistic infection
  • 0 views
  • 16 Feb, 2024
  • 5 locations
A Comparison of Rocuronium 0.6 mg/kg and Remifentanil 2 g/kg in Elderly Patients Over 80 Years

The number of elderly patients above 80 years is increasing and a large proportion of these patients will require surgery and anesthesia. During anesthesia neuromuscular blocking agents (NMBA) are administered to facilitate intubating conditions and reduce the trauma to the larynx and vocal cords. There is a risk of residual …

rocuronium
residual block
general anesthesia
residual neuromuscular block
neuromuscular blockade
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Investigation of an Abdominal Compression Device

This study is applicable to patients undergoing lower lung or abdomen stereotactic ablative body radiotherapy (SABR) treatment. The purpose of the ACE 01 study is to identify if, the volume of healthy tissue within the treatment area and therefore subsequent side effects, can be reduced by using a commercially available …

lung cancer
adrenal
stereotactic body radiation therapy
primary cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location